极端环境放线菌的分离及多相分类研究

本文综述了放线菌分类学研究的目的和作用，分析了放线菌分类学的历史和现状，介绍了当前放线菌多相分类研究中所采用的技术方法及适用范围。同时还重点介绍了极端高温、低温、高盐放线菌分离及分类研究的进展。从云南采集高温温泉水样、火山口土样，从云南、新疆等地采集雪山土样，从新疆、青海等地采集盐碱土样进行放线菌分离，对不同极端环境下的放线菌分离方法进行探讨，并对分离到的部分典型放线菌菌株采用形态特征、培养特征，生理生化测定，细胞化学组份分析，DNA G+C mol%和DNA同源性测定，以及16SrDNA全序列分析等相结合的多相分类技术进行系统的分类研究。从表型、基因型及系统发育三个不同层次对其分类地位进行了最终确定。其中，分离自云南洱源温泉的菌株YIM60013和腾冲火山口的菌株YIM60032分别确定为高温放线菌属的两个新种：白色高温放线菌（Thermoactznomyces albus sp. nov.）和云南高温放线菌（Termoactomyces yunnanensis sp. nov.）；分离自新疆北疆地区的一株低温放线菌菌株，结合其形态特征、细胞化学组份及16S rDNA序列分析将其鉴定为链霉菌的一个新种，北疆链霉菌（Streptomyces beijiangensis sp. nov.）；来自新疆盐碱土样的6株嗜盐放线菌菌株YIM90001-90006中，菌株YIM90001被命名为嗜盐普氏菌新种(Prauserella halophila sp. nov.），菌株YIM90005被 命名为脱卤普氏菌新种（Prauserella dehalogenans sp. nov.），菌株YIM90002和YIM90003鉴定为拟诺卡氏菌科中的链单抱菌新属Streptomonospora gen. nov.）和它的两个新种：菌株YIM90002定为盐生链单抱菌新种(Streptomonospora saline sp. nov.），菌株YIM90003定为白色链单抱菌新种(Streptomonospora alba sp. nov.）；菌株YIM90004和YIM90006分别被确定为拟诺卡氏菌属的一个新种和一个亚种：新疆拟诺卡氏菌新种（Nocardopsi sxiniangensis sp. nov.）和嗜阿拉伯糖新疆拟诺卡氏菌亚种( Noocardiopsi sxiniangensis subsp．arabicus subsp．nov，）。

调节LDLR及VCAM-1基因表达的微生物代谢产物的研究

为了筛选对靶基因LDLR和VCAM-1的表达具有调节作用的生物活性物质，建立了两个基于重组人细胞系的高通量的筛选模型，使用荧光素酶在96-孔版上来筛选对上述靶基因的表达具有调节作用的微生物代谢产物。模型之一是来自于人肝HepG2细胞系的重组L39细胞，用于筛选增加LDLR报告基因表达的生物活性物质，以期发现新的具有降胆固醇作用的药物。筛选之二为来源于细胞系ECV304的重组细胞株Nl-14,用于筛选抑制VCAM-1基因表达的活性物质，以期发现治疗风湿性关节炎等免疫性疾病治疗的药物。上述筛选系统均是稳定转染的细胞系，分别含有与荧光素酶报告基因相融合的LDLR或VCAM-1基因的转录调节元件。通过对6300株微生物的总计12600个样品的筛选，共发现和分离了17个活性化合物并进行了结构解析。其中两个被命名为Cladospolede D和Zelkovamycin的化合物被确定为新的化合物。由真菌 FO-6605的发酵液提取得到的一个化合物对LDLR报告基因的表达具有很强的上调作用，其SC200为1 Onmol/L a使用荧光标记的LDL检测到该化合物对于HepG2细胞膜上LDLR具有剂量依赖的增强作用。由真菌FO-5897的发酵液中分离到了一个已知的化合物Ascofuranone，该化合物曾经被报道具有降血脂抗肿瘤的活性。值得注意的是我们首次发现了该化合物同时具有抑制 VCAM-1报告基因表达和增强LDLR报告基因表达的作用，该发现有可能会对其降血脂作用的深入研究提供帮助。由海洋真菌FT-0012产生的化合物Cladospolede D为一个12-员环的大环内酷类的化合物，该化合物对两个测活系统均显示出无选择性的抑制作用形态学研究显示该真菌属于Cladosporiun属。另外一个由土壤放线菌K96-670产生的新化合物为一个环八肤类的化合物，经~1H~1-H COSY,~(13)C-H COSY,~(13)C-~1H HMQC, ~(15)N-~1H HMQC,~(15)-~1N HHMBC等波谱学研究得知该化合物的分子结构中含有六个非普通的氨基酸和两个普通氨基酸。该化合物对VCAM-I报告基因的表达显示出非常好的选择性的抑制活性，其IC50值为9.5ug/ml.形态学的研究表明该菌株属于链霉菌属。 在筛选过程中从来源于云南省西双版纳的土壤中分离到了一株编号为YIM1272的放线菌，经包括形态学、生理一生化和16S rDNA在内的分类学研究，确定该菌株为链霉菌属的一个新种，被命名为佩版纳链霉菌，(Streptomyces.bannaensis．sp.nov）。

繁茂膜海绵中放线菌的鉴定及S19抗菌素主要特性的研究

近年的研究表明，海绵微生物是某些海绵天然产物的真正产生者。因此，人们将海绵微生物作为开发海绵天然产物的重要来源之一。采用琼脂块法和液体扩散法，从分离自中国黄渤海大连海域的海绵优势种—繁茂膜海绵的28株放线菌中筛选到4株具有抗菌活性的放线菌，并对它们进行生物学鉴定。采用经典和现代分类鉴定方法，对4株具有抗菌活性的繁茂膜海绵放线菌的形态特征、培养特征、生理生化特征、细胞壁化学组分和16SrRNA序列进行了研究，得出种水平的鉴定结果：Hmp-S14为西唐氏链霉菌Streptomycessetonii；Hmp-S19为灰色链霉菌Streptomyces griseus；Hmp-S24为桔橙小单抱菌Micromonospora aurantiaca；Hmp-S26为生二素链霉菌Streptomyces ambifaciens。在四株具有抗菌活性的繁茂膜海绵放线菌中，菌株Hmp-S19的抗菌活性优于其它三株，并且与已报道的20多种灰色链霉菌菌株有不同的生理生化特性，故进一步优化其发酵条件并初步研究了S19抗菌素的理化性质。通过单因子和均匀设计实验，优化菌株Hmp-S19摇瓶发酵条件。确定最佳发酵培养基：玉米粉0.6％，葡萄糖0.1％，豆饼粉0.5％，NaCl 0.3％，KH2PO40.08％，CaCO30.08％，MgSO40.02％；最佳发酵条件：接种龄30h，接种量5％，初始pH7．0，发酵时间96h，装液量100ml／50ml，培养温度28 ℃。应用二剂量法测定519一抗菌素的相对效价，为5154μ/ml，较原始发酵培养基和发酵条件（3364μ/ml）提高了53％。通过pH纸层析和捷克八溶剂系统纸层析试验，初步判定519抗菌素为两性、非水溶性I型抗菌素。Hmp-S19发酵液经预处理、萃取、硅胶柱层析、制备薄层层析等步骤，对S19抗菌素进行分离纯化得粗制品，并进行了液 相色谱一质谱检测。

嗜盐和嗜碱放线菌的分离及多相分类研究

本文综述了放线菌分类学研究的意义和进展，分析了放线菌分类学研究特点及发展趋势；同时综述了嗜盐、嗜碱放线菌的研究进展，分析了嗜盐和嗜碱放线菌研究的重要性和意义。通过对采自渤海沿岸盐场、青海盐湖、张北盐湖、曲周、保定等地盐碱和高盐的样品进行嗜盐和嗜碱放线菌的分离，建立了适于嗜盐和嗜碱放线菌的分离培养条件；找到了广适性的嗜盐放线菌培养用培养基；发现了嗜盐放线菌多数耐碱的规律。采用形态培养特征、生理生化测定、细胞化学组分分析、DNA G＋C mol％测定以及DNA同源性分析和165 rDNA序列为基础的系统发育分析等相结合的多相分类技术对分离得到的部分典型菌株系统地进行了分类研究，从表型、基因型和系统发育三个层次对其分类地位进行了确定。本研究发现嗜盐放线菌新属新种1个，为波状盐场放线菌新属新种（Actinoosalterria undulata gen.nov．sp．nov），嗜盐放线菌新种4个，分别是：沧州拟诺卡氏菌(Nocardiopsl's cangzhouensis sp．nov．）、塘沽拟诺卡氏菌(Nocardiopsis tangguensis sp.nov）、茶卡拟诺卡氏菌(NocardioPs沽chakaensis)和盐场链霉菌(Streptomyces salinarum sP.nov.）；发现嗜碱放线菌新种2个，分别是；布尔津拟诺卡氏菌（NocardioPsis buerjinensis sp.nov．）和城墙拟诺卡氏菌（Nocardiopsis rampartis sp.nov．）；另有2株嗜碱放线菌鉴定为达松维尔拟诺卡氏菌，2株嗜碱放线菌鉴定为产气味拟诺卡氏。论文研究中还初步建立了放线菌磷酸类脂高效液相色谱测定的方法与测定条件。

吸水链霉菌、放线菌Sp.253和金色毛壳菌的次生代谢产物研究

链霉菌是十分重要的一类放线菌，绝大多数的抗生素都由该类细菌产生。毛壳属真菌是一类重要的丝状真菌，从中也发现有很多结构新颖、活性独特的活性物质。因此本论文对两株链霉菌的活性成分及一株金毛壳菌的次生代谢产物进行了研究。 1．从吸水链霉菌（Streptomyces hygroscopicus 1.358）液态发酵产物（乙酸乙酯提取物）中分离得到3个化合物，通过波谱方法鉴定为RK955A (1)、Nigericin（2）、Elaiophylin（3）。以青霉素耐药-金黄色葡萄球菌作为指示菌的抗菌活性测定表明，三者均具有较强抗菌活性。 2．通过抗肿瘤体外活性筛选模型筛选得到得到一株链霉属土壤放线菌，从中分离得到六个化合物：苯乙酰胺（4）、苯丙酰胺（5）、肉桂酰胺（6）、3-（N-（甲酰胺基）乙酰基）吲哚（7）、鸟苷磷酸（8）、鸟苷（9）。 3．从金色毛壳菌（Chaetomium aureus）的固态培养物中分离得到13个化合物，利用波谱方法将其鉴定为：金毛壳菌素A（10）、金毛壳菌素B（11）、Eugenetin（12）、Eugenitol（13）、Chaetoquadrin A（14）、Chaetoquadrin B（15）、Chaetoquadrin G（16）、Chaetoquadrin H（17）、Chaetochromin A（18）、Sterigmatocystin（19）、O-methylsterigmatocystin（20）、3β-羟基-麦角甾-5，7，22-三烯（21）和过氧麦角甾醇（22）。 4．综述了聚醚类抗生素的结构、生物合成、生物活性及作用机理。 The genus Streptomyces (Actinomycetes) is an important group of microbe. Most antibiotics known nowdays are discovered from species of Streptomyces. The fungi of the genus Chaetomium have attracted much attention because various kinds of secondary metabolites with diverse bioactivities have been found from them. Thus, the bioactive compounds from two strains of Streptomyces and the secondary metabolites of Chaetomium aureus were investigated. 1. Three compounds were isolated from the ethyl acetate extract of the fermentation broth of Streptomyces hygroscopicus. They are identified to be elaiophylin (1), nigericin (2), and antibiotic RK955A (3) on the basis of their spectroscopic data. Compounds 1-3 possess antibacterial activities against Staphyloccocus aureus. 2. It was found that the extract of the fermented broth of a strain of Actinomycetes could inhibit some tumor cel lines. Separation of the bioactive fraction led to the isolation of six compounds. They were characterized to be phenylacetamide (4), phenylpropylamide (5), trans-cinnamamide (6), 3- (N- (formylmethyl) acetamide) indole (7), guanylicacid (8), and guanosine (9). 3. From the fermented broth of Chaetomium aureus, 13 compounds were isolated for the first time. They were determined to be chaetomiumycin A (10), chaetomiumycin B (11), eugenetin (12), eugenitol (13), chaetoquadrin A (14), chaetoquadrin B (15), chaetoquadrin G (16), chaetoquadrin H (17), chaetochromin A (18), sterigmatocystin (19), O-methylsterigmatocystin (20), 3β-hydroxyergosta-5, 7, 22-triene (21) and peroxy-ergosterol (22). Compounds 10 and 11 are new ones. 4. Structure, biosynthesis, biological activity, and mechanisms of polyether antibiotics were reviewed.

链霉菌S227抗耐药菌活性成分的研究

本论文以从四川峨嵋山森林土壤中分离筛选获得的一株产抗耐药性活性化合物的链霉菌S227为材料，对发酵液中活性物质的分离纯化及抗耐药性活性进行了研究。 建立了抗耐药性活性的定性、定量检测方法。建立的管蝶法活性定量检测的标准回归方程为：D=4.8229Ln(C)+3.6326 R=0.9972 ；纸片法活性定量检测的标准回归方程为：D=5.5Ln(C)-12.794 R=0.999。 根据建立的样品活性的检测方法，测定了发酵液的初始活性。实验证明活性物质的温度、pH稳定性好。 通过活性的定性、定量追踪方法，分别利用等体积的石油醚、乙酸乙酯、正丁醇在不同的pH梯度下萃取，确定了pH3条件下正丁醇能最大程度的萃取活性物质，说明活性物质极性很大。对正丁醇萃取相经过两次硅胶柱层析及薄层层析分离得到具有抗耐药菌活性的纯化样品S227-4。 经过核磁共振氢谱、碳谱数据分析初步确定S227-4为四聚糖，通过糖的水解实验初步确定S227-4由葡萄糖和半乳糖组成。 纸片法活性检测表明S227-4具有抗耐药菌活性。采用MIC测定法对该样品抗耐药活性进行研究。在证明该样品本身不具有抗菌活性的基础上，以临床分离的耐药性金黄色葡萄球菌为指示菌，考察了该样品与抗生素联合使用时对耐药菌抗生素MIC（最小抑菌浓度）值的影响，结果表明在不影响菌体生长的浓度条件下，该样品能明显降低多株耐药菌对多种抗生素的MIC值，不同程度地恢复所测试耐药菌对相应抗生素的敏感性。如S227-4与青霉素钠联用可以使S. aureus 12352的MIC降低8倍，而与红霉素联用可以使S. aureus 12334的MIC降低128倍。 The purification process and the activity of the anti bacterial drug resistance compounds produced by Streptomyces S227 isolated from the forest soil sample of the Mountain E’MEI in Sichuan Province were studied in this thesis. Quantitative and qualitative activity assay methods of the active compounds were established. The regression equation of the tube method was D=4.8229Ln(C)+3.6326, R=0.9972. The regression equation of the paper method was D=5.5Ln(C)-12.794, R=0.999. According to the established activity assay method, the incipient activity of the broth was evaluated. And it was proved that the stability of the active compounds was good. By quantitative and qualitative activity tracing method, petroleum ether, ethyl acetate and butanol were used to extract the active compounds at different pH. The result showed that butanol was the most effective agent for active component recovery at pH3. From the butanol extraction a purified sample, S227-4, was isolated by silica gel column chromatography and thin-layer chromatography . S227-4 was proved to be a tetra- saccharide by 1H-NMR and 13C-NMR. And its monosaccharides include glucose and galactose by hydrolysate analysis. The anti-drug resistant activity of S227-4 was tested in vitro by MICs assay using different drug resistant Staphylococcus aureus strains isolated clinically. The sample itself showed no anti-microbial activity in growth inhibitory experiment, but when it was used together with different antibiotics, it could remarkably decrease the MICs of different clinically isolated drug-resistant bacterial strains to these antibiotics. For example, when S227-4 was used with penicillin, the MIC of S. aureus 12352 decreased 8 times compared with that when penicillin was used alone. Meanwhile when it was used with erythromycin the MIC of S. aureus 12334 deceased 128 times compared with erythromycin alone.

克拉维酸产生菌的诱变育种与发酵工艺优化研究

以克拉维酸产生菌棒状链霉菌Streptomyces clavuligerus CCRC11518（ATCC 27064）III50为出发菌株, 首先比较各种物理和化学诱变剂处理对其克拉维酸生物合成的影响, 确定了亚硝基胍为棒状链霉菌诱变育种的诱变剂及其处理剂量: 2mg/ml、40min. 经浓度为2mg/ml的亚硝基胍处理40min后, 采用新颖理性化筛选方法, 通过逐步筛选自身代谢产物抗性突变株、克拉维酸抗性突变株和链霉素抗性突变株, 最终得到一株克拉维酸高产菌VI118(效价633μg/ml), 其克拉维酸效价是出发菌株(效价377μg/ml)的167.9%. 该高产突变株在琼脂斜面培养基上连续传接10代, 克拉维酸效价保持稳定. 通过单因子和多因子摇瓶正交试验, 对高产菌株VI118的发酵条件进行了研究, 确定最佳发酵条件: 甘油60g, 水解植物蛋白 60g, KH2PO4 0.5 g, 玉米浆 7.5g, MnSO4•H2O 0.34g, MgSO4•7H2O 0.99g, FeSO4•7H2O 0.56g, 蒸馏1000ml, pH 7.0, 发酵培养基装量20ml/250ml三角瓶, 接种量10％, 培养温度28ºC, 220r/min摇床培养72h后测定效价. 在最佳发酵条件下克拉维酸效价达到651μg/ml, 同时把初始发酵培养基的昂贵成分替换为廉价的工业原料. 通过摇瓶分批补料试验, 得到最佳补料物质和补料方式：在上述最佳发酵条件下, 分别在发酵培养48h、56h、64h、72h时补加4ml无菌水, 80h发酵结束, 克拉维酸效价达到905μg/ml. 在不增加原料成本的情况下通过摇瓶补料方式克拉维酸效价为未补料的139.0％, 总产量为未补料的264％. By a novel rational screening method, mutant Streptomyces clavuligerus CCRC11518（ATCC 27064）III50（titres 377μg/ml）, as the clavulanic acid-producing parent strain, was treated by NTG (2mg/ml) for 40min, and the self-generated metabolites resistant mark, the clavulanic acid resistant mark and the streptomycin resistant mark were added step by step. Finally, the mutant VI118（titres 633μg/ml）with the three marks was obtained. The clavulanic acid productivity of this mutant was increased by 167.9% compared with the parent strain. After reproducing 10 generations on the agar medium slant, the productivity of this mutant was stable. The optimum fermentation conditions were established as followings: glycerol 60g, acid hydrolyzed vegetable protein 60g, KH2PO4 0.5g, corn steep liquor 7.5g, MnSO4•H2O 0.34g, MgSO4•7H2O 0.99g, FeSO4•7H2O 0.56g, distilled water 1 liter, pH 7.0, 20ml in 250ml shake-flask, inoculation 10%(v/v), fermentation temperature 28ºC, rotation speed 220 r/min, time 72h. The clavulanic acid productivity was 651μg/ml, while used the low-priced industrial raw materials. After studying on fed-batch in the shake-flask, the optimum fed-batch manner was obtained: under optimum fermentation conditions, at 48h, 56h, 64h and 72h, adding 4ml distilled water into each flask, fermentation ending at 80h. The clavulanic acid productivity was increased by 139% compared with no fed-batch, meanwhile the total yield was increased by 264%.

石油污染土壤生物修复过程中微生物生态研究

The analysis on microbiological ecology for four types of oil contaminates soils showed that the bacteria utilizing the oil as carbon sources increase,wheras the fugi become less .Zooloea and Bacillu are the dominant bacteria ; Mocor and Cunninghamella ,and Fursarium are the dominant fungi streptomyces take the superiority among the actinomyces.The anaiysis on esterase activity showed that the microbes above mentioned have abilies of degrading esters. The biodeg radationrates are 55.45%,56.74%,38.37% and 45.19%respectively,after 53 days,the biodegradation rate can be increased by 12.6% when the dominant microbes are added.

Chandrananimycins A-C: Production of novel anticancer antibiotics from a marine Actinomadura sp isolate M048 by variation of medium composition and growth conditions

In our screening of marine actinomycetes for bioactive principles, three novel antibiotics designated as chandrananimycin A (3c), B (3d) and C (4) were isolated from the culture broth of a marine Actinomadura sp. isolate M045. The structures of the new antibiotics were determined by detailed interpretation of mass, 1 D and 2 D NMR spectra.

胶州湾海洋链霉菌抑菌活性筛选、2株抑菌活性菌株的鉴定及次级代谢产物的研究

本文对256株胶州湾海洋链霉菌进行了抑菌活性的筛选，并选取10株典型菌株进行化学筛选，获得2株有研究价值的菌株。通过大规模发酵，获得纯化的次级代谢产物，进行了结构解析。通过与其他5株活性菌株的16S rRNA基因序列比较，并结合生理生化、形态特征和培养特征分析，探讨了这两株菌的分类地位。 　　采用液体扩散法，选用金黄色葡萄球菌、大肠杆菌、绿脓杆菌、八叠球菌、隐球菌、白色念珠菌、Mucor miehei (TÜ 284)和Streptomyces viridochromogenes (TÜ57) 8株受试菌进行抑菌活性的筛选，结果22%的菌株显示出对至少一种受试菌具有抑制作用(抑菌圈Æ ³ 8 mm)。根据菌株的形态特征和抑菌活性特点，选择M024、M028、M042、M083、M086、M095、M097、M124、M134和M226 10株链霉菌进行化学筛选。考察了8种培养基和4种培养条件，结果发现菌株M095在Meat extract培养基、pH 6.5、28℃和95 r/min条件下，菌株M097在Meat extract培养基、pH 7.8、 28℃、95 r/min(条件Ⅰ)和M2+培养基、pH 7.8、 35℃、110 r/min(条件Ⅱ)条件下，可供进一步研究。 对菌株M095(24 L规模)和M097(Ⅰ为30 L规模，Ⅱ为14 L规模)进行发酵，采用乙酸乙酯提取和柱层析分离纯化次级代谢产物，通过ESI-MS、EI-MS、1H-NMR和13C-NMR等波谱解析，鉴定出次级代谢产物的结构。发现菌株M095产生一抑菌活性很强的化合物全霉素，首次证实该全霉素具有抑制丝状真菌的作用；菌株M097主要产生10个化合物，其中8个具有不同程度的生物活性，另外两个化合物中，Aloesaponaria Ⅱ为首次从微生物野生菌株(wild strain)中获得，化合物Cui D为一新结构的蒽醌类化合物。 经分子鉴定，初步认为本实验分离的7株活性海洋链霉菌分属于4个链霉菌类群，结合生理生化、形态特征和培养特征分析，认为菌株M095可能为灰色链霉菌的变种，M097可能为球孢类群中的一个新种。

四株海洋放线菌遗传转化体系的研究

作者所在的课题组，自1998年以来从胶州湾海泥中陆续分离了800株海洋放线菌，并从4株放线菌中分离出了12个新结构活性化合物。选择产生新颖抗肿瘤抗生素的海洋放线菌M045和M048，产全霉素的海洋放线菌M095和产蒽醌类化合物的海洋放线菌M097为研究材料，建立了海洋放线菌的遗传转化体系，为海洋放线菌的遗传工程操作及天然化合物组合生物合成奠定了基础。 （1）通过接合转移建立了菌株M045的遗传转化体系。用来源于蓝藻Anacystis nidulans UTEX625的别藻蓝蛋白基因验证了转化体系的有效性。通过PCR及基因组步移方法获得长度为1709bp的部分聚酮合成酶（PKS）基因，分析其同放射菌素基因具有同源性，利用基因中断插入失活该基因，但未获得突变株。因此尝试通过反向遗传学方法，克隆该菌株中新骨架抗肿瘤抗生素——中国霉素的生物合成基因簇，本研究已经构建了该菌株Fosmid基因组文库，对基因组文库的筛选工作正在进行中。 （2）利用PEG-介导的质粒pIJ702转化原生质体和接合转移两种方法均成功获得菌株M048的转化子，其中接合转移率高达10-4。菌株M048来源于高盐的海洋环境，维持原生质体所需渗透压与模式菌株—变铅青链霉菌（Streptomyces lividans）有很大差异，本研究对菌株M048原生质体形成和再生的各种因素进行了优化，获得了渗透压稳定剂蔗糖最佳浓度为0.4M。 质粒pIJ8600整合于菌株M048染色体上，对该转化株的抑菌活性、薄层层析（TLC）以及HPLC-MS进行了分析。结果表明，同野生菌株相比，该转化株对7种受试菌的抑菌活性显著增强，TLC显示差异的化合物条带，HPLC-MS显示化合物组分有差异。因此质粒pIJ8600的整合，引起菌株次级代谢产物生物合成途径的改变，使有抑菌活性的化合物大量累积。 从菌株M048染色体上克隆获得了1196bp的部分PKS基因，通过基因中断插入失活该基因，结果显示M048突变株次级代谢产物抑菌活性增强，HPLC分析发现显著差异。初步分析该PKS基因的中断使菌株体内某些生物合成途径受阻，而大量合成抗菌活性强的chandrananimycin C，或者产生了抑菌活性强的其它化合物。 （3）本研究成功建立了菌株M095的接合转移体系。M095/pIJ8600转化株的生物学活性分析并未发现差异，表明该菌株染色体上的整合位点（attB）是中性（neutral）的。通过PCR以及基因组步移的方法克隆获得了该菌株的部分糖基转移酶基因，该基因中断突变株对4株受试菌的抑菌活性增强，HPLC显示有差异，表明该糖基转移酶基因参与了菌株M095活性次级代谢产物的生物合成过程。 （4）对于菌株M097，用接合转移法成功获得了转化子。实现了别藻蓝蛋白基因的重组表达，并纯化了表达产物，体外试验表明其具有清除羟基自由基能力。结果表明来源于蓝藻的外源基因可以在海洋放线菌体内有效表达和正确折叠，初步验证了本研究所建立的海洋放线菌遗传转化体系的稳定性及有效性。对M097/pIJ8600转化株的生物学活性分析，未发现差异，表明该菌株染色体上的整合位点是中性的。 本论文首次将基因工程技术引入四株海洋放线菌，建立了海洋放线菌自身的基因转移系统，为利用基因工程技术改造海洋放线菌的天然化合物生物合成途径提供了方法。对部分PKS基因中断突变株的生物学活性及化学分析，初步揭示了通过遗传转化方法进行化合物组合生物合成的可行性。

青海高寒草甸土壤放线菌区系研究

2001～2002年从海北高寒草甸生态系统采集土样,用不同方法从中分离放线菌300余株,根据其形态和分类特征,分别归入小单孢菌属(Micromonospora)、诺卡氏菌属(Nocardia)、糖多孢菌属(Saccharopolyspora)、原小单孢菌属(Promicromonospora)和链霉菌属(Streptomyces),并将链霉菌归入7个类群.同时对230株中温菌和110株低温菌的部分酶活性及其对真菌和细菌的拮抗性进行了测定,发现链霉菌不仅具有许多酶活性,而且对真菌和细菌有拮抗性.

Biodiscovery of natural products from microbes associated with Irish coastal sponges

Marine sponges have been an abundant source of new metabolites in recent years. The symbiotic association between the bacteria and the sponge has enabled scientists to access the bacterial diversity present within the bacterial/sponge ecosystem. This study has focussed on accessing the bacterial diversity in two Irish coastal marine sponges, namely Amphilectus fucorum and Eurypon major. A novel species from the genus Aquimarina has been isolated from the sponge Amphilectus fucorum. The study has also resulted in the identification of an α–Proteobacteria, Pseudovibrio sp. as a potential producer of antibiotics. Thus a targeted based approach to specifically cultivate Pseudovibrio sp. may prove useful for the development of new metabolites from this particular genus. Bacterial isolates from the marine sponge Haliclona simulans were screened for anti–fungal activity and one isolate namely Streptomyces sp. SM8 displayed activity against all five fungal strains tested. The strain was also tested for anti–bacterial activity and it showed activity against both against B. subtilis and P. aeruginosa. Hence a combinatorial approach involving both biochemical and genomic approaches were employed in an attempt to identify the bioactive compounds with these activities which were being produced by this strain. Culture broths from Streptomyces sp. SM8 were extracted and purified by various techniques such as reverse–phase HPLC, MPLC and ash chromatography. Anti–bacterial activity was observed in a fraction which contained a hydroxylated saturated fatty acid and also another compound with a m/z 227 but further structural elucidation of these compounds proved unsuccessful. The anti–fungal fractions from SM8 were shown to contain antimycin–like compounds, with some of these compounds having different retention times from that of an antimycin standard. A high–throughput assay was developed to screen for novel calcineurin inhibitors using yeast as a model system and three putative bacterial extracts were found to be positive using this screen. One of these extracts from SM8 was subsequently analysed using NMR and the calcineurin inhibition activity was con rmed to belong to a butenolide type compound. A H. simulans metagenomic library was also screened using the novel calcineurin inhibitor high–throughput assay system and eight clones displaying putative calcineurin inhibitory activity were detected. The clone which displayed the best inhibitory activity was subsequently sequenced and following the use of other genetic based approaches it became clear that the inhibition was being caused by a hypothetical protein with similarity to a hypothetical Na+/Ca2+ exchanger protein. The Streptomyces sp. SM8 genome was sequenced from a fragment library using Roche 454 pyrosequencing technology to identify potential secondary metabolism clusters. The draft genome was annotated by IMG/ER using the Prodigal pipeline. The Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession AMPN00000000. The genome contains genes which appear to encode for several polyketide synthases (PKS), non–ribosomal peptide synthetases (NRPS), terpene and siderophore biosynthesis and ribosomal peptides. Transcriptional analyses led to the identification of three hybrid clusters of which one is predicted to be involved in the synthesis of antimycin, while the functions of the others are as yet unknown. Two NRPS clusters were also identified, of which one may be involved in gramicidin biosynthesis and the function of the other is unknown. A Streptomyces sp. SM8 NRPS antC gene knockout was constructed and extracts from the strain were shown to possess a mild anti–fungal activity when compared to the SM8 wild–type. Subsequent LCMS analysis of antC mutant extracts confirmed the absence of the antimycin in the extract proving that the observed anti–fungal activity may involve metabolite(s) other than antimycin. Anti–bacterial activity in the antC gene knockout strain against P. aeruginosa was reduced when compared to the SM8 wild–type indicating that antimycin may be contributing to the observed anti–bacterial activity in addition to the metabolite(s) already identified during the chemical analyses. This is the first report of antimycins exhibiting anti–bacterial activity against P. aeruginosa. One of the hybrid clusters potentially involved in secondary metabolism in SM8 that displayed high and consistent levels of gene–expression in RNA studies was analysed in an attempt to identify the metabolite being produced by the pathway. A number of unusual features were observed following bioinformatics analysis of the gene sequence of the cluster, including a formylation domain within the NRPS cluster which may add a formyl group to the growing chain. Another unusual feature is the lack of AT domains on two of the PKS modules. Other unusual features observed in this cluster is the lack of a KR domain in module 3 of the cluster and an aminotransferase domain in module 4 for which no clear role has been hypothesised.

A tale of two bioprocesses

Bioprocesses use microorganisms or cells in order to produce and/or obtain some desired products. Nowadays these strategies appear as a fundamental alternative to the traditional chemical processes. Amongst the many advantages associated to their use in the chemical, oil or pharmaceutical industries, their low cost, easily scale-up and low environmental impact should be highlighted. This work reports two examples of bioprocesses as alternatives to traditional chemical processes used by the oil and pharmaceutical industries. In the first part of this work it was studied an example of a bioprocess based on the use of microorganisms in enhanced oil recovery. Currently, due to high costs of oil and its scarcity, the enhanced oil recovery techniques become very attractive. Between the available techniques the use of microbial enhanced oil recovery (MEOR) has been highlighted. This process is based on the stimulation of indigenous microorganisms or by the injection of microorganism consortia to produce specific metabolites and hence increase the amount of oil recovered. In the first chapters of this work the isolation of several microorganisms from samples of paraffinic Brazilian oils is described, and their tensioactive and biodegradability properties are presented. Furthermore, the chemical structures of the biosurfactants produced by those isolates were also characterized. In the final chapter of the first part, the capabilities of some isolated bacteria to enhance the oil recovery of paraffinic Brazilian oils entrapped in sand-pack columns were evaluated. In the second part of this work it was investigated aqueous two-phase systems or aqueous biphasic systems (ABS) as extractive strategies for antibiotics directly from the fermented broth in which they are produced. To this goal, several aqueous two-phase systems composed of ionic liquids (ILs) and polymers were studied for the first time and their phase diagrams were determined. The novel ATPS appear as effective and economic methods to extract different biomolecules or/and biological products. Thus, aiming the initial antibiotics extraction purpose it was studied the influence of a wide range of ILs and polymers in the aqueous two-phase formation ability, as well as their influence in the partitioning of several type-molecules, such as amino acids, alkaloids and dyes. As a final chapter it is presented the capacity of these novel systems to extract the antibiotic tetracycline directly from the fermented broth of Streptomyces aureofaciens.

Distribution and bioactive potential of soil actinomycetes from different ecological habitats

Emergence of drug resistance among pathogenic bacteria to currently available antibiotics has intensified the search for novel bioactive compounds from unexplored habitats. In the present study actinomycetes were isolated from two relatively unexplored and widely differing habitats such as mountain and wetlands and their ability to produce antibacterial substances were analyzed. Pure cultures of actinomycetes were identified by morphological and biochemical tests. Various genera of actinomycetes encountered included Nocardia, Pseudonocardia, Streptomyces, Nocardiopsis, Streptosporangium, Micromonospora, Rhodococcus, Actinosynnema, Nocardiodes, Kitasatosporia, Gordona, Intrasporangium and Streptoalloteichus. The frequency of occurrence of each genus was found to vary with sample. About 47% of wetland isolates and 33% of mountain isolates were identified as various species of Nocardia. The isolated strains differed among themselves in their ability to decompose proteins and amino acids and also in enzyme production potential. Antibiotic activities of these actinomycetes were evaluated against 12 test pathogenic bacteria by well diffusion method using agar wells in glycerol-yeast extract agar. About 95% of actinomycete isolates from wetland ecosystem and 75% of highland isolates suppressed in different degrees the growth of test pathogens. Relatively high antibacterial activity among these isolates underlined their potential as a source of novel antibiotics.